Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.

ABSTRACT:

SUBMITTER: Hyak JM 

PROVIDER: S-EPMC9631640 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature